Drug combination could make curative surgery possible for some liver cancer patients

A combination of the kinase-inhibitor drug cabozantinib and the immunotherapy drug nivolumab can make curative surgery possible in some liver cancer patients who would normally not be considered surgery candidates. Results published July 29 in the journal Nature Cancer by researchers at the Johns Hopkins Kimmel Cancer Center describe the benefits of this drug combination. Among 15 people with hepatocellular […]

Read more

Liver cancer symptoms: The uncomfortable sign on your skin that could signal the disease

Liver cancer develops when abnormal cells start to divide and grow in an uncontrolled way in the liver. It is a relatively rare form of cancer, with around 5,900 cases diagnosed each year in the UK. It is rare but serious nonetheless: the treatment outcomes are not as hopeful other forms of cancer due to the underlying damage that is […]

Read more